Loading insider details...
Beta
Latest Form 4 (Jul 30, 2026): Grant/Award of 7,500 CGEN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | COMPUGEN LTD (CGEN) | Grant/Award | 7,500 | n/a |
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Disposition to Issuer | 96,000 | n/a |
| Jun 24, 2025 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 40,000 | n/a |
| Jun 27, 2024 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 48,000 | n/a |
| Jun 23, 2023 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 48,000 | n/a |
| Jul 6, 2022 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 96,000 | n/a |